NCT02092441

Brief Summary

Randomized controlled trial comparing inhalation of isopropyl alcohol vs placebo (normal saline) pads to treat nausea in emergency department patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 18, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 20, 2014

Completed
12 days until next milestone

Study Start

First participant enrolled

April 1, 2014

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
2 months until next milestone

Results Posted

Study results publicly available

July 31, 2015

Completed
Last Updated

May 23, 2016

Status Verified

April 1, 2016

Enrollment Period

7 months

First QC Date

March 18, 2014

Results QC Date

July 3, 2015

Last Update Submit

April 15, 2016

Conditions

Keywords

NauseaVomitingAntiemetic

Outcome Measures

Primary Outcomes (1)

  • Nausea Verbal Numerical Rating Scale (0-10) at 10 Minutes Post Intervention

    Primary outcome is nausea and vomiting measured on a scale from 0 ("no nausea") to 10 ("worst nausea imaginable") Verbal Numerical Response Scale (VNRS) at 10 minutes post intervention.

    10 minutes post intervention

Secondary Outcomes (1)

  • Verbal Numerical Rating Scale Pain Score (0-10) at 10 Minutes Post Intervention

    10 minutes post intervention

Other Outcomes (1)

  • Satisfaction Measured on a 5-point Likert Scale

    10 minutes post intervention

Study Arms (2)

Alcohol prep pad group

ACTIVE COMPARATOR

isopropyl alcohol prep pad

Other: Alcohol prep pad group

Normal Saline prep pad

PLACEBO COMPARATOR

normal saline prep pad

Other: Normal Saline prep pad

Interventions

Subjects inhale scent of alcohol pad

Alcohol prep pad group

Subjects inhale scent of placebo (normal saline) pads

Normal Saline prep pad

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age range of 18-65 years of age
  • complaint of nausea and or vomiting
  • ability to breathe through nose
  • ability to read and write English

You may not qualify if:

  • allergy to isopropyl alcohol
  • pregnancy or pregnancy status unknown to subject. Pregnancy test only if part of clinical course.
  • recent upper respiratory infection
  • recent intake of cefoperazone, disulfiram, or metronidazole or any other medications that are known produce nausea when exposed to alcohol.
  • use of antiemetic or psychoactive drug within 24 hours
  • alcohol abuse
  • nicotine within last 4 hrs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emergency Department, Brooke Army Medical Center

Fort Sam Houston, Texas, 78234, United States

Location

Related Publications (8)

  • Burleigh-Flayer HD, Gill MW, Strother DE, Masten LW, McKee RH, Tyler TR, Gardiner T. Isopropanol 13-week vapor inhalation study in rats and mice with neurotoxicity evaluation in rats. Fundam Appl Toxicol. 1994 Oct;23(3):421-8. doi: 10.1006/faat.1994.1123.

    PMID: 7835543BACKGROUND
  • Gill MW, Burleigh-Flayer HD, Strother DE, Masten LW, McKee RH, Tyler TR, Gardiner TH. Isopropanol: acute vapor inhalation neurotoxicity study in rats. J Appl Toxicol. 1995 Mar-Apr;15(2):77-84. doi: 10.1002/jat.2550150204.

    PMID: 7782562BACKGROUND
  • Burleigh-Flayer H, Garman R, Neptun D, Bevan C, Gardiner T, Kapp R, Tyler T, Wright G. Isopropanol vapor inhalation oncogenicity study in Fischer 344 rats and CD-1 mice. Fundam Appl Toxicol. 1997 Apr;36(2):95-111. doi: 10.1006/faat.1996.2284.

    PMID: 9143479BACKGROUND
  • Cotton JW, Rowell LR, Hood RR, Pellegrini JE. A comparative analysis of isopropyl alcohol and ondansetron in the treatment of postoperative nausea and vomiting from the hospital setting to the home. AANA J. 2007 Feb;75(1):21-6.

    PMID: 17304779BACKGROUND
  • Winston AW, Rinehart RS, Riley GP, Vacchiano CA, Pellegrini JE. Comparison of inhaled isopropyl alcohol and intravenous ondansetron for treatment of postoperative nausea. AANA J. 2003 Apr;71(2):127-32.

    PMID: 12776641BACKGROUND
  • Pellegrini J, DeLoge J, Bennett J, Kelly J. Comparison of inhalation of isopropyl alcohol vs promethazine in the treatment of postoperative nausea and vomiting (PONV) in patients identified as at high risk for developing PONV. AANA J. 2009 Aug;77(4):293-9.

    PMID: 19731848BACKGROUND
  • Wang SM, Hofstadter MB, Kain ZN. An alternative method to alleviate postoperative nausea and vomiting in children. J Clin Anesth. 1999 May;11(3):231-4. doi: 10.1016/s0952-8180(99)00035-5.

    PMID: 10434220BACKGROUND
  • Beadle KL, Helbling AR, Love SL, April MD, Hunter CJ. Isopropyl Alcohol Nasal Inhalation for Nausea in the Emergency Department: A Randomized Controlled Trial. Ann Emerg Med. 2016 Jul;68(1):1-9.e1. doi: 10.1016/j.annemergmed.2015.09.031. Epub 2015 Dec 8.

MeSH Terms

Conditions

NauseaVomiting

Interventions

Ethanol

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AlcoholsOrganic Chemicals

Results Point of Contact

Title
Dr. Michael D. April
Organization
Brooke Army Medical Center

Study Officials

  • Kenneth L Beadle, MPAS, BS

    BAMC

    PRINCIPAL INVESTIGATOR
  • Curtis J Hunter, M.D.

    BAMC

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Residency Associate Program Director for Research

Study Record Dates

First Submitted

March 18, 2014

First Posted

March 20, 2014

Study Start

April 1, 2014

Primary Completion

November 1, 2014

Study Completion

June 1, 2015

Last Updated

May 23, 2016

Results First Posted

July 31, 2015

Record last verified: 2016-04

Locations